Tolerances induction by 'megadose' hematopoietic transplants

Transplantation

Volumn 65, Issue 10, 1998, Pages 1386-1393

  Rachamim, Nurit ^a   Gan, Judith ^a   Segall, Harry ^a   Krauthgamer, Rita ^a   Marcus, Hadar ^a   Berrebi, Alain ^b   Martelli, Massimo ^c   Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD34 ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LEUKEMIA; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; CELL COMMUNICATION; CYTOTOXIC T LYMPHOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LEUKOCYTE COUNT; MIXED LYMPHOCYTE CULTURE; PHENOTYPE; PHYSIOLOGY; RADIATION EXPOSURE; STEM CELL;

ANTIGENS, CD34; CELL COMMUNICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE TOLERANCE; LEUKOCYTE COUNT; LYMPHOCYTE CULTURE TEST, MIXED; PHENOTYPE; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032571946     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805270-00017     Document Type: Article

References (49)

1. Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983; 61: 341.
2. O'Reilly RJ, Keever CA, Small TN, Brochstein J. The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodefic Rev 1989; 1: 273.
3. Gale RP, Reisner Y. Graft rejection and graft-versus-host disease: mirror images. Lancet 1986; 1: 1468.
4. Marmont AM, Horowitz MM, Gale RP, et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120.
5. Aversa F, Tabilio A, Terenzi A, et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948.
6. Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995; 1: 1268.
7. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58.
8. Spangrude GJ, Brooks DM, Tumas DB. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 1995; 85: 1006.
9. Ogata H, Bradley WG, Inaba M, Ogata N, Ikehara S, Good RA. Long-term repopulation of hematolymphoid cells with only a few hemopoietic stem cells in mice. Proc Natl Acad Sci USA 1995; 92: 5945.
10. Zijlmans JM, Visser JW, Kleiverda K, Kluin PM, Willemze R, Fibbe WE. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci USA 1995; 92: 8901.
11. Strober S. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu Rev Immunol 1984; 2: 219.
12. Lapidot T, Faktorowich Y, Lubin I, Reisner Y. Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+CD4- and not by CD8-CD4+ thymocytes. Blood 1992; 80: 2406.
13. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436.
14. Thomas JM, Carver FM, Cunningham PR, Olson LC, Thomas FT. Kidney allograft tolerance in primates without chronic immunosuppression - the role of veto cells. Transplantation 1991; 51: 198.
15. Martelli MF, Terenzi A, Velardi A, et al. Successful engraftment of haploidentical mismatched transplants. Exp Hematol 1996; 24: 1158.
16. Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for acute leukaemia with HLA-A and B non-identical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981; ii: 327.
17. Reisner Y, Friedrich W, Fabian I. A shorter procedure for preparation of E-rosette-depleted bone marrow for transplantation. Transplantation 1986; 42: 312.
18. Heimfeld S, Fogarty B, McGuire K, Williams S, Berenson RJ. Peripheral blood stem cell mobilization after stem cell factor or G-CSF treatment: rapid enrichment for stem and progenitor cells using the CEPRATE immunoaffinity separation system. Transplant Proc 1992; 24: 2818.
19. Brugger W, Henschler R, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994; 84: 1421.
20. Ryser JE, MacDonald HR. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol 1979; 122: 1691.
21. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
22. Miller RG, Derry H. A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol 1979; 122: 1502.
23. Rammensee HG, Nagy ZA, Klein J. Suppression of cell-mediated lymphocytotoxicity against minor histocompatibility antigens mediated by Lyt-1 + Lyt-2+ T cells of stimulator-strain origin. Eur J Immunol 1982; 12: 930.
24. Muraoka S, Miller RG. Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Immunol 1983; 131: 45.
25. Rammensee HG, Fink PJ, Bevan MJ. Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen. J Immunol 1984; 133: 2390.
26. Fink PJ, Rammensee HG, Benedetto JD, Staerz UD, Lefrancois L, Bevan MJ. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes. J Immunol 1984; 133: 1769.
27. Fink PJ, Rammensee HG, Bevan MJ. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them. J Immunol 1984; 133: 1775.
28. Claesson MH, Miller RG. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity. J Exp Med 1984; 160: 1702.
29. Miller RG, Muraoka S, Claesson MH, Reimann J, Benveniste P. The veto phenomenon in T-cell regulation. Ann NY Acad Sci 1988; 532: 170.
30. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science 1991; 252: 1424.
31. Thomas JM, Verbanac KM, Smith JP, et al. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation 1995; 59: 245.
32. Lapidot T, Terenzi A, Singer TS, Reisner Y. Size of bone marrow inoculum versus number of donor-type cells used for presensitization: a murine model for bone marrow allograft rejection in leukemia patients. Blood 1987; 70: 309a.
33. Lapidot T, Terenzi A, Singer TS, Salomon O, Reisner Y. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 1988; 73: 2025.
34. Aguila HL, Akashi K, Domen J, et al. From stem cells to lymphocytes: biology and transplantation. Immunol Rev 1997; 157: 13.
35. Sykes M, Szot GL, Swenson KA, Pearson DA. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997; 3: 783.
36. Reisner Y, Ben-Bassat I, Douer D, Kaploon A, Schwartz E, Ramot B. Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation. Proc Natl Acad Sci USA 1986; 83: 4012.
37. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia: identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 1987; 43: 842.
38. Bordignon C, Keever CA, Small TN, et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia. II. In vitro analyses of host effector mechanisms. Blood 1989; 74: 2237.
39. Boussiotis VA, Gribben JG, Freeman GJ, Nadler LM. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr Opin Immunol 1994; 6: 797.
40. Blazar BR, Taylor PA, Linsley PS, Vallera DA. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood 1994; 83: 3815.
41. Gribben JG, Guinan EC, Boussiotis VA, et al. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool. Blood 1996; 87: 4887.
42. - Hematopoietic stem cells and non-alloreactive T cells exhibit a potent tolerizing activity in sub-lethally irradiated recipients: a model for tolerance induction by "megadose" stem cell transplants. Acta Haematologica 1997; 98: 10.
43. Allison JP. CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994; 6: 414.
44. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13: 622.
45. Zhang Y, Yasumizu R, Sugiura K, et al. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation for the mechanism of tolerance induction by portal vein injection. Eur J Immunol 1994; 24: 1558.
46. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996; 271: 1723.
47. Rondelli D, Andrews RG, Hansen JA, Ryncarz R, Faerber MA, Anasetti C. Alloantigen presenting function of normal human CD34+ hematopoietic cells. Blood 1996; 88: 2619.
48. Snodgrass R, Keller G. Clonal fluctuation within the haematopoietic system of mice reconstituted with retrovirus-infected stem cells. EMBO J 1987; 6: 3955.
49. Szilvassy SJ, Cory S. Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood 1994; 84: 74.